Navigation Links
Obesity Drug may Hold Potent Cancer Treatments

Boffins are designing potent cancer treatments using their knowledge about an obesity drug, orlistat (Xenical or Alli) that was found to kill cancer cells in the laboratory .

The drug binds and interacts with a protein found in tumour cells and blocks the protein's function and causes cell death.

The study was conducted by a team of researchers including Steven Kridel and W. Todd Lowther at Wake Forest University School of Medicine.

As part of the study, scientists analysed prostate cancer cells to see which enzymes were expressed at high levels to develop treatments to inhibit those enzymes to stop tumour growth.

Researchers found that a protein known as fatty acid synthase was expressed at high levels in prostate tumour cells, and was fairly absent in normal cells.

Earlier researches have shown that the protein was found in many tumour cells including breast, colon, ovarian, liver, lung and brain.

"High levels of fatty acid synthase correlate with a poor prognosis so it is a great treatment target. This makes an exciting treatment target because theoretically you don't have to worry about harming nearby healthy tissue," Kridel said.

Scientists used X-ray crystallography to get a three-dimensional snapshot of the drug interacting with the protein.

"Understanding this drug-protein interaction is essential for designing new drugs," Lowther said.

Researchers then screened hundreds of thousands of compounds to identify the ones that interacted with cancer cells in the same way as orlistat and narrowed the list of possibilities down to a dozen.

The researchers will now work to create potent cancer treatments by testing the drugs in animals and then in human cancer patients.

The findings of the study were published in Nature Structural and Molecular Biology.


'"/>




Page: 1

Related medicine news :

1. Lean Protein Could Be Key to Obesity Drugs
2. Obesity raises IVF miscarriage risk
3. Obesity a risk for pancreatic cancer
4. Obesity shortens lifespan
5. Is Obesity a risk factor?
6. Obesity a global problem
7. Obesity increases health costs
8. Obesity in children a risk factor for diabetes
9. Decrease of Hunger Hormone after Obesity Surgery
10. Obesity risk for immobilized adults
11. Obesity risk can be reduced by eating breakfast regularly
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... 2017 , ... A recent report from the Wisconsin Institute ... 2015-16 school year across Wisconsin’s public schools, charter schools, and private schools participating ... student test score performance, the report’s limited analyses fail to provide answers as ...
(Date:4/25/2017)... Las Vegas, NV (PRWEB) , ... April 25, ... ... teeth can now choose a modern procedure that achieves results in a fraction ... orthodontist in Las Vegas, NV, with Significance Dental Specialists, now offers this ...
(Date:4/25/2017)... Atlanta, GA (PRWEB) , ... April 25, 2017 , ... ... to their neck and back pain with a reputable physician in their area, announces ... The CRM protects patient information for patients who are looking for reputable physicians to ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... predictive analytics to its patient care management module. Using this new feature, sleep ... patient has been initiated on continuous positive airway pressure (CPAP), oral, or other ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... large animal healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, ... development and joint health in horses at the immunologic level. , The scientifically-developed ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017  SARES•REGIS Group leased the first of ... Conejo Spectrum Business Park in Thousand ... Inc. , a biopharmaceutical company developing meaningful therapies ... have been underserved by scientific innovation, with an ... autoimmune and infectious disease. Before commencement ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, ... on providing the Urology, Uro/Gyn and Gynecology markets with ... the first quarter ended March 31, 2017 after the ... The Company will host a conference call and ... on Tuesday, May 2, 2017 at 4:30 p.m. Eastern ...
(Date:4/18/2017)... Research and Markets has announced the addition of the ... ... to grow at a CAGR of 6.35% during the period 2017-2021. ... been prepared based on an in-depth market analysis with inputs from ... prospects over the coming years. The report also includes a discussion ...
Breaking Medicine Technology: